^‘

{¹Assistant Professor, Department of Neurology} {²Assistant Professor, Department of Physiology} Topiwala National Medical College

& B. Y. L. Nair Charitable Hospital, Mumbai, Maharashtra, INDIA.

Email: drdeepali1985@yahoo.com

REFERENCES

1. Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci 2002; 14: 223–36; Discussion, 222
2. S. Lim and A. E. Lang, “The nonmotor symptoms of Parkinson’s disease: an overview,” Movement Disorders, vol. 25, supplement 1, pp. S123–S130, 2010.
3. Neurological disorders report. Public health challenges.(2016). http://www.who.int/mental_health/neurology/neurological_disorders_report_web.pdf
4. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol (2006) 5(6):525–35.
5. de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al.. Prevalence of Parkinson’s disease in the elderly: the Rotterdam study. Neurology (1995) 45(12):2143–6.
6. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, et al.. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology (2000) 54(11 Suppl 5):S21–3.
7. Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) (2017) 124(8):901–5.
8. Tanner CM, Aston DA. Epidemiology of Parkinson’s disease and akinetic syndromes. Curr Opin Neurol 2000; 13: 427–30
9. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007;22:41-7
10. Braak H, Bohl JR, Müller CM, et al.. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 2006; 21: 2042–51.
11. Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, et al.. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013 Jan 15;80(3):276-81.
12. Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, et al.. Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov Disord. 2013 Oct 7
13. P. Martinez-Martin, C. Rodriguez-Blazquez, K. Abe et al.., “International study on the psychometric attributes of the NonMotor Symptoms Scale in Parkinson disease,” Neurology, vol. 73, no. 19, pp. 1584–1591, 2009.
14. Chandrasekaran P, Mugundhan K. Non-motor symptoms of Parkinson’s disease: Its prevalence across the various stages of Parkinson’s disease and its correlation with the severity and duration of the disease. Stanley Med J 2017;4:13-7.
15. Ravan A, Ahmad FM, Chabria S, Gadhari M, Savant Sankhla C. Non-motor symptoms in an Indian cohort of Parkinson’s disease patients and correlation of progression of non-motor symptoms with motor worsening. Neurol India 2015;63:166-74.
16. P. Barone, A. Antonini, C. Colosimo et al.., “The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease,” Movement Disorders, vol. 24, no. 11, pp. 1641–1649, 2009.
17. P. Martinez-Martin, A. H. V. Schapira, F. Stocchi et al.., “Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients,” Movement Disorders, vol. 22, no. 11, pp. 1623–1629, 2007.
18. H. Li, M. Zhang, L. Chen et al.., “Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson’s disease,” Movement Disorders, vol. 25, no. 16, pp. 2740–2746, 2010.
19. Krishnan S, Sarma MAG, Sarma S, Kishore A. Do non-motor symptoms in Parkinson’s disease differ from normal aging? Mov Disord 2011;26:2110-13.
20. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord 2007;22:1901-11.
21. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123: 331–9.
22.  Shahrul Azmin, Abdul Manaf Khairul Anuar, Hui Jan Tan, Wan Yahya Nafisah, Azman Ali Raymond, Othman Hanita, Shamsul Azhar Shah, and Mohamed Ibrahim Norlinah. Nonmotor Symptoms in a Malaysian Parkinson’s Disease Population. Hindawi Publishing Corporation Parkinson’s Disease Volume 2014, Article ID 472157,7.
23. Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR, Gutiérrez C, et al.. Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms. J Neurol (2013) 260(5):1332–8.
24. Cosentino C, Nuñez Y, Torres L: Frequency of non-motor symptoms in Peruvian patients with Parkinson's disease [Article in English, Spanish]. Arq Neuropsiquiat. 2013, 71:216-21.